Definition of Infertility and Indications for Fertility Evaluation: Consensus Document
DOI:
https://doi.org/10.63264/zvpr3e66Keywords:
infertility, restorative reproductive medicine, subfertility, fertility evaluation, recurrent pregnancy loss, time to pregnancy, fecundabilityAbstract
Infertility is a clinical condition that is recognized by the symptom of an inability to conceive through sexual intercourse or to sustain a pregnancy, with that symptom indicating underlying male and/or female pathology.
METHODOLOGY
This definition of infertility was developed through a structured, consensus-informed process involving broad stakeholder engagement. Initially, multiple definitions currently used by various medical professional organizations were reviewed, and a definition document was drafted and submitted to the Board of Directors of the International Institute for Restorative Reproductive Medicine (IIRRM). All IIRRM members were invited to provide feedback on the draft. Approximately 2,500 individuals and 44 organizations from 92 countries were then invited to review the proposed document, representing clinical, scientific, patient, policy, and advocacy perspectives. Submitted comments were reviewed thematically, with suggested revisions evaluated for clarity, clinical relevance, inclusiveness, and consistency with contemporary restorative reproductive medicine. Following this review, 3 substantive changes, 18 minor changes, and 15 citation corrections were incorporated into the final draft which resulted in a revised definition intended to better reflect the medical, social, and practical realities of modern infertility evaluation and care. Final approval by the IIRRM Board of Directors was unanimous.
References
1. Hippocrates. Generation. Nature of the Child. Diseases IV. Nature of Women. Barrenness. Potter P, trans. Cambridge, MA: Harvard University Press; 2012. Loeb Classical Library 520.
2. Avicenna, & Gruner, O C (1985). A treatise on the Canon of medicine of Avicenna : incorporating a translation of the first book (Special ed.). Classics of Medicine Library.
3. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Vanderpoel S. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009 Nov;92(5):1520-4. doi: 10.1016/j.fertnstert.2009.09.009. DOI: https://doi.org/10.1016/j.fertnstert.2009.09.009
4. Marchbanks PA, Peterson HB, Rubin GL, Wingo PA. Research on infertility: definition makes a difference. The Cancer and Steroid Hormone Study Group. Am J Epidemiol. 1989 Aug;130(2):259-67. doi:10.1093/oxfordjournals.aje.a115332. DOI: https://doi.org/10.1093/oxfordjournals.aje.a115332
5. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005 May;20(5):1144-7. doi: 10.1093/humrep/deh870. DOI: https://doi.org/10.1093/humrep/deh870
6. Habbema JD, Collins J, Leridon H, Evers JL, Lunenfeld B, te Velde ER. Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod. 2004 Jul;19(7):1497-501. doi: 10.1093/humrep/deh303. DOI: https://doi.org/10.1093/humrep/deh303
7. World Health Organization (2023). Infertility prevalence estimates: 1990–2021. World Health Organization. https://iris.who.int/handle/10665/366700.
8. Larsen U. Research on infertility: which definition should we use? Fertil Steril. 2005 Apr;83(4):846-52. doi: 10.1016/j.fertnstert.2004.11.033. DOI: https://doi.org/10.1016/j.fertnstert.2004.11.033
9. Mascarenhas MN, Cheung H, Mathers CD, Stevens GA. Measuring infertility in populations: constructing a standard definition for use with demographic and reproductive health surveys. Popul Health Metr. 2012 Aug 31;10(1):17. doi: 10.1186/1478-7954-10-17. DOI: https://doi.org/10.1186/1478-7954-10-17
10. Gurunath S, Pandian Z, Anderson RA, Bhattacharya S. Defining infertility--a systematic review of prevalence studies. Hum Reprod Update. 2011 Sep-Oct;17(5):575-88. doi: 10.1093/humupd/dmr015. DOI: https://doi.org/10.1093/humupd/dmr015
11. Practice Committee of the American Society for Reproductive Medicine, American Society for Reproductive Medicine, Washington, DC.. Definition of infertility: a committee opinion. Fertil Steril. 2023 Dec;120(6):1170. doi: 10.1016/S0015-0282(23)01971-4. DOI: https://doi.org/10.1016/S0015-0282(23)01971-4
12. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020 Mar;113(3):533-535. doi:10.1016/j.fertnstert.2019.11.025. DOI: https://doi.org/10.1016/j.fertnstert.2019.11.025
13.Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013 Jan;99(1):63. doi:10.1016/j.fertnstert.2012.09.023. DOI: https://doi.org/10.1016/j.fertnstert.2012.09.023
14. Polis CB, Cox CM, Tunçalp Ö, McLain AC, Thoma ME. Estimating infertility prevalence in low-to-middle-income countries: an application of a current duration approach to Demographic and Health Survey data. Hum Reprod. 2017 May 1;32(5):1064-1074. doi:10.1093/humrep/dex025. DOI: https://doi.org/10.1093/humrep/dex025
15. Stanford JB, Dunson DB. Effects of sexual intercourse patterns in time to pregnancy studies. Am J Epidemiol. 2007 May 1;165(9):1088-95. doi:10.1093/aje/kwk111. DOI: https://doi.org/10.1093/aje/kwk111
16. Johnson S, Stanford JB, Warren G, Bond S, Bench-Capon S, Zinaman MJ. Increased Likelihood of Pregnancy Using an App-Connected Ovulation Test System: A Randomized Controlled Trial. J Womens Health (Larchmt). 2020 Jan;29(1):84-90. doi:10.1089/jwh.2019.7850. DOI: https://doi.org/10.1089/jwh.2019.7850
17. Robinson JE, Wakelin M, Ellis JE. Increased pregnancy rate with use of the Clearblue Easy Fertility Monitor. Fertil Steril. 2007 Feb;87(2):329-34. doi:10.1016/j.fertnstert.2006.05.054. DOI: https://doi.org/10.1016/j.fertnstert.2006.05.054
18. Stanford JB, Smith KR, Dunson DB. Vulvar mucus observations and the probability of pregnancy. Obstet Gynecol. 2003 Jun;101(6):1285-93. doi: 10.1016/s0029-7844(03)00358-2. DOI: https://doi.org/10.1097/00006250-200306000-00025
19. Faust L, Bradley D, Landau E, Noddin K, Farland LV, Baron A, Wolfberg A. Findings from a mobile application-based cohort are consistent with established knowledge of the menstrual cycle, fertile window, and conception. Fertil Steril. 2019 Sep;112(3):450-457.e3. doi:10.1016/j.fertnstert.2019.05.008. DOI: https://doi.org/10.1016/j.fertnstert.2019.05.008
20. Keulers MJ, Hamilton CJ, Franx A, Evers JL, Bots RS. The length of the fertile window is associated with the chance of spontaneously conceiving an ongoing pregnancy in subfertile couples. Hum Reprod. 2007 Jun;22(6):1652-6. doi:10.1093/humrep/dem051. DOI: https://doi.org/10.1093/humrep/dem051
21. Najmabadi S, Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, Stanford JB. Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts. Paediatr Perinat Epidemiol. 2020 May;34(3):318-327. doi:10.1111/ppe.12644. DOI: https://doi.org/10.1111/ppe.12644
22. Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. BMJ. 2000 Nov 18;321(7271):1259-62. doi: 10.1136/bmj.321.7271.1259. DOI: https://doi.org/10.1136/bmj.321.7271.1259
23. Bull JR, Rowland SP, Scherwitzl EB, Scherwitzl R, Danielsson KG, Harper J. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. NPJ Digit Med. 2019 Aug 27;2:83. doi: 10.1038/s41746-019-0152-7. DOI: https://doi.org/10.1038/s41746-019-0152-7
24. Malliou-Becher MN, Herrmann PM, Freis A, Freundl-Schütt T, Wallwiener LM, Baur S, Fehring RJ, Gnoth C, Mallios A, Strowitzki T, Frank-Herrmann P. Variations in ovulation time and menstrual cycle characteristics: analysis of a prospective long-term cohort study. Hum Reprod. 2026 Jun 1;41(6):959-968. doi:10.1093/humrep/deag057. DOI: https://doi.org/10.1093/humrep/deag057
25. Colombo B, Masarotto G. Daily fecundability: first results from a new data base. Demogr Res. 2000 Sep 6;3:[39] DOI: https://doi.org/10.4054/DemRes.2000.3.5
26. Dahlberg B, Yates S, Kelly L, et al. The Dawn of the FemTech Revolution. McKinsey & Company. February 14, 2022.
27. Rampazzo F, Raybould A, Rampazzo P, Barker R, Leasure D. "UPDATE: I'm pregnant!": Inferring global downloads and reasons for using menstrual tracking apps. Digit Health. 2024 Nov 21; 10:20552076241298315. doi:10.1177/20552076241298315. DOI: https://doi.org/10.1177/20552076241298315
28. Broad A, Biswakarma R, Harper JC. A survey of women's experiences of using period tracker applications: Attitudes, ovulation prediction and how the accuracy of the app in predicting period start dates affects their feelings and behaviours. Womens Health (Lond). 2022 Jan-Dec;18:17455057221095246. doi:10.1177/17455057221095246. DOI: https://doi.org/10.1177/17455057221095246
29. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med. 1995 Dec 7; 333(23):1517-21. doi:10.1056/NEJM199512073332301. DOI: https://doi.org/10.1056/NEJM199512073332301
30. Ali R, Gürtin ZB, Harper JC. Do fertility tracking applications offer women useful information about their fertile window? Reprod Biomed Online. 2020 Sep 11:S1472-6483(20)30509-5. doi:10.1016/j.rbmo.2020.09.005. DOI: https://doi.org/10.1016/j.rbmo.2020.09.005
31. Bigelow JL, Dunson DB, Stanford JB, Ecochard R, Gnoth C, Colombo B. Mucus observations in the fertile window: a better predictor of conception than timing of intercourse. Hum Reprod. 2004 Apr;19(4):889-92. doi:10.1093/humrep/deh173. DOI: https://doi.org/10.1093/humrep/deh173
32. Evans-Hoeker E, Pritchard DA, Long DL, Herring AH, Stanford JB, Steiner AZ. Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive. Fertil Steril. 2013 Oct;100(4):1033-1038.e1. doi:10.1016/j.fertnstert.2013.06.002. DOI: https://doi.org/10.1016/j.fertnstert.2013.06.002
33. Ecochard R, Duterque O, Leiva R, Bouchard T, Vigil P. Self-identification of the clinical fertile window and the ovulation period. Fertil Steril. 2015 May;103(5):1319-25.e3. doi:10.1016/j.fertnstert.2015.01.031. DOI: https://doi.org/10.1016/j.fertnstert.2015.01.031
34. Mu Q, Fehring RJ. Efficacy of achieving pregnancy with fertility-focused intercourse. MCN Am J Matern Child Nurs. 2014 Jan-Feb;39(1):35-40. doi:10.1097/NMC.0b013e3182a76b88 DOI: https://doi.org/10.1097/NMC.0b013e3182a76b88
35. Duane M, Stanford JB, Porucznik CA, Vigil P. Fertility Awareness-Based Methods for Women's Health and Family Planning. Front Med (Lausanne). 2022 May 24;9:858977. doi:10.3389/fmed.2022.858977. DOI: https://doi.org/10.3389/fmed.2022.858977
36. Frank-Herrmann P, Gnoth C, Baur S, Strowitzki T, Freundl G. Determination of the fertile window: reproductive competence of women--European cycle databases. Gynecol Endocrinol. 2005 Jun;20(6):305-12. doi: 10.1080/09513590500097507. DOI: https://doi.org/10.1080/09513590500097507
37. Hilgers TW, Prebil AM. The ovulation method--vulvar observations as an index of fertility/infertility. Obstet Gynecol. 1979 Jan;53(1):12-22.
38. Stanford JB, White GL, Hatasaka H. Timing intercourse to achieve pregnancy: current evidence. Obstet Gynecol. 2002 Dec;100(6):1333-41. doi:10.1016/s0029-7844(02)02382-7. DOI: https://doi.org/10.1097/00006250-200212000-00027
39. Favaro C, Pearson JT, Rowland SP, Jukic AM, Chelstowska M, Berglund Scherwitzl E, Scherwitzl R, Gemzell Danielsson K, Harper J. Time to Pregnancy for Women Using a Fertility Awareness Based Mobile Application to Plan a Pregnancy. J Womens Health (Larchmt). 2021 Nov;30(11):1538-1545. doi:10.1089/jwh.2021.0026. DOI: https://doi.org/10.1089/jwh.2021.0026
40. Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Reproductive Endocrinology and Infertility; Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, Jindal S, Kalra S, Mersereau J, Reindollar R, Shannon CN, Steiner A, Tanrikut C, Taylor H, Yauger B. Optimizing natural fertility: a committee opinion. Fertil Steril. 2022 Jan;117(1):53-63. doi: 10.1016/j.fertnstert.2021.10.007. DOI: https://doi.org/10.1016/j.fertnstert.2021.10.007
41. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003 Sep;18(9):1959-66. doi:10.1093/humrep/deg366. DOI: https://doi.org/10.1016/S0015-0282(03)01866-1
42. Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol. 2004 Jan;103(1):51-6. doi:10.1097/01.AOG.0000100153.24061.45. DOI: https://doi.org/10.1097/01.AOG.0000100153.24061.45
43. Annual Capri Workshop Group. Towards a more pragmatic and wiser approach to infertility care. Hum Reprod. 2019 Jul 8;34(7):1165-1172. doi:10.1093/humrep/dez101. DOI: https://doi.org/10.1093/humrep/dez101
44. Tańska K, Gietka-Czernel M, Glinicki P, Kozakowski J. Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes. Front Endocrinol (Lausanne). 2023 Jan 11;13:1049665. doi:10.3389/fendo.2022.1049665.. DOI: https://doi.org/10.3389/fendo.2022.1049665
45. Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, Patil M, Rees DA, Berry L, Cree MG, Zhao H, Norman RJ, Dokras A, Piltonen T; Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026 Jun 6;407(10545):2329-2339. doi:10.1016/S01406736(26)00717-8. DOI: https://doi.org/10.1016/S0140-6736(26)00717-8
46. Van Gestel H, Bafort C, Meuleman C, Tomassetti C, Vanhie A. The prevalence of endometriosis in unexplained infertility: a systematic review. Reprod Biomed Online. 2024 Sep;49(3):103848. doi:10.1016/j.rbmo.2024.103848. DOI: https://doi.org/10.1016/j.rbmo.2024.103848
47. World Health Organization. Polycystic ovary syndrome. Updated January 22, 2026. Available at: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome/. Accessed June 8, 2026.
48. Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015 Jul 31;7:745-63. doi:10.2147/IJWH.S70314. DOI: https://doi.org/10.2147/IJWH.S70314
49. Piltonen TT, Koskenkari N, Koivuaho E, Morin-Papunen L, Hurskainen E, Gissler M, Arffman RK, Ollila MM. Increased mortality in polycystic ovary syndrome- a cohort study. Eur J Endocrinol. 2026 Apr 30;194(5):724-731. doi:10.1093/ejendo/lvag080. DOI: https://doi.org/10.1093/ejendo/lvag080
50. Blom JN, Velez MP, McClintock C, Shellenberger J, Pudwell J, Brogly SB, Bougie O. Endometriosis and cardiovascular disease: a population-based cohort study. CMAJ Open. 2023 Mar 7;11(2):E227-E236. doi:10.9778/cmajo.20220144. DOI: https://doi.org/10.9778/cmajo.20220144
51. Singh SS, Allaire C, Al-Nourhji O, Bougie O, Bridge-Cook P, Duigenan S, Kroft J, Lemyre M, Leonardi M, Leyland N, Maheux-Lacroix S, Wessels J, Wahl K, Yong PJ. Guideline No. 449: Diagnosis and Impact of Endometriosis - A Canadian Guideline. J Obstet Gynaecol Can. 2024 May;46(5):102450. doi:10.1016/j.jogc.2024.102450. DOI: https://doi.org/10.1016/j.jogc.2024.102450
52. Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC. Endometriosis Typology and Ovarian Cancer Risk. JAMA. 2024 Aug 13;332(6):482-489. doi:10.1001/jama.2024.9210. DOI: https://doi.org/10.1001/jama.2024.9210
53. Kvaskoff M, Mahamat-Saleh Y, Farland LV, Shigesi N, Terry KL, Harris HR, Roman H, Becker CM, As-Sanie S, Zondervan KT, Horne AW, Missmer SA. Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update. 2021 Feb 19;27(2):393-420. doi:10.1093/humupd/dmaa04. DOI: https://doi.org/10.1093/humupd/dmaa045
54. Ganci D, Steeper M, Polyakov A, et al. The effectiveness and safety of restorative reproductive medicine compared to ART: a systematic review. Fertil Steril. 2026; 125, 993-1001. doi: 10.1016/j.fertnstert.2026.03.039 DOI: https://doi.org/10.1016/j.fertnstert.2026.03.039
55. Boyle PC. Understanding Restorative Reproductive Medicine. J Restorative Reprod Med (2025) 1(7):1–2. Epub 2025 Sep 17. doi: 10.63264/f0b0xh81. DOI: https://doi.org/10.63264/f0b0xh81
56. Wesselink AK, Rothman KJ, Hatch EE, Mikkelsen EM, Sørensen HT, Wise LA. Age and fecundability in a North American preconception cohort study. Am J Obstet Gynecol. 2017 Dec;217(6):667.e1-667.e8. doi:10.1016/j.ajog.2017.09.002. DOI: https://doi.org/10.1016/j.ajog.2017.09.002
57. Practice Committee of the American Society for Reproductive Medicine. Recurrent pregnancy loss: a committee opinion. Fertil Steril. 2026 Jun;125(6):1023-1041. doi: 10.1016/j.fertnstert.2026.03.001. DOI: https://doi.org/10.1016/j.fertnstert.2026.03.001
58. Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S, Kirkman-Brown J, Coomarasamy A. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod. 2012 Oct;27(10):2908-17. doi:10.1093/humrep/des261. DOI: https://doi.org/10.1093/humrep/des261
59. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD002859. doi:10.1002/14651858.CD002859.pub2. DOI: https://doi.org/10.1002/14651858.CD002859.pub2
60. Stanford JB, Smith KR, Varner MW. Impact of Instruction in the Creighton Model Fertilitycare System on Time to Pregnancy in Couples of Proven Fecundity: Results of a Randomised Trial. Paediatr Perinat Epidemiol (2014) 28(5):391–9. doi:10.1111/ppe.12141 DOI: https://doi.org/10.1111/ppe.12141
61. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021 Nov;116(5):1255-1265. doi:10.1016/j.fertnstert.2021.08.038. DOI: https://doi.org/10.1016/j.fertnstert.2021.08.038
62. Stanford JB, Carpentier PA, Meier BL, Rollo M, Tingey B. Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. BMC Pregnancy Childbirth. 2021 Jul 7;21(1):495. doi:10.1186/s12884-021-03946-8. DOI: https://doi.org/10.1186/s12884-021-03946-8
63. Stanford JB, Parnell TA, Boyle PC. Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. J Am Board Fam Med. 2008 Sep-Oct;21(5):375-84. doi:10.3122/jabfm.2008.05.070239. DOI: https://doi.org/10.3122/jabfm.2008.05.070239
64. European Society of Human Reproduction and Embryology (ESHRE). Factsheet on Infertility – Prevalence, Treatment and Fertility Preservation. Brussels: ESHRE; 2024.
65. Stanford JB, Parnell T, Kantor K, Reeder MR, Najmabadi S, Johnson K, Musso I, Hartman H, Tham E, Winter I, Galczynski K, Carus A, Sherlock A, Golden Tevald J, Barczentewicz M, Meier B, Carpentier P, Poehailos K, Chasuk R, Danis P, Lipscomb L. International Natural Procreative Technology Evaluation and Surveillance of Treatment for Subfertility (iNEST): enrollment and methods. Hum Reprod Open. 2022 Aug 9;2022(3):hoac033. doi:10.1093/hropen/hoac033. DOI: https://doi.org/10.1093/hropen/hoac033
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Monica Minjeur, Tracey A. Parnell, Joseph B. Stanford, Phil A. Boyle, José Antonio Arraztoa, Zoreslava Horodenchuk, Natalia Suszczewicz, Kevin McCarthy
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC-BY-4.0 permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.